Modular Cell-Surface-to-Solution CRISPR-Cas12a Platform for Wash-Free Quantification of Cell−Surface Proteins on Living Cells

Abstract Cell−surface proteins are important biomarkers for cell phenotyping, disease diagnosis, therapeutic evaluation, and drug screening. However, their quantitative analysis on intact living cells remains challenging because conventional methods often require cell lysis, fixation, repeated washing, extensive sample processing, or bulky instrumentation. Herein, we developed a modular and reconfigurable cell-surface-to-solution CRISPR-Cas12a platform for wash-free quantitative analysis of cell−surface proteins on intact living cells. Aptamer recognition of extracellularly accessible targets deblocks a DNA activator, thereby activating Cas12a trans-cleavage in solution and converting localized cell−surface recognition into amplified fluorescence while maintaining a low background in the absence of targets. Using EpCAM as a model target, we engineered a split dual-aptamer architecture that enabled cooperative target recognition, efficient activator deblocking, and low-background signal amplification. The platform achieved sensitive EpCAM detection with a limit of detection of 32 fM and enabled live-cell analysis down to 2 cells/μL. It distinguished cell populations with different surface EpCAM levels and quantitatively monitored epithelial−mesenchymal transition-associated changes in cell−surface EpCAM abundance. Coordinated redesign of the target-responsive nucleic acid components extended the platform to PTK7 detection and the analysis of drug-induced cell−surface PTK7 remodeling. Coupling the system to a lateral flow readout enabled portable visual detection. This work establishes a modular and reconfigurable CRISPR-Cas12a sensing strategy for wash-free amplified quantification of cell−surface proteins on living cells, providing a convenient tool for investigating their dynamic remodeling during physiological and pathological processes and therapeutic responses, as well as for drug screening.

Authors

Institutions

Publication Details

Journal
Analytical Chemistry
Published
2026-10-16
DOI
https://doi.org/10.1021/acs.analchem.6c05289
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modular Cell-Surface-to-Solution CRISPR-Cas12a Platform for Wash-Free Quantification of Cell−Surface Proteins on Living Cells

De‐Ming Kong, Shun-Li Wu, Li−Na Zhu, Qing-Nan Li et al.
Analytical Chemistry
Advanced biosensing and bioanalysis techniques
article

Modular Cell-Surface-to-Solution CRISPR-Cas12a Platform for Wash-Free Quantification of Cell−Surface Proteins on Living Cells

De‐Ming Kong, Shun-Li Wu, Li−Na Zhu, Qing-Nan Li, Wen-Bo Sun, Kai-Di Li, Yan Tan, Xiao-Yun Hou, Qi-Fan Yang, Man-Ying Li
article en

Abstract

Abstract Cell−surface proteins are important biomarkers for cell phenotyping, disease diagnosis, therapeutic evaluation, and drug screening. However, their quantitative analysis on intact living cells remains challenging because conventional methods often require cell lysis, fixation, repeated washing, extensive sample processing, or bulky instrumentation. Herein, we developed a modular and reconfigurable cell-surface-to-solution CRISPR-Cas12a platform for wash-free quantitative analysis of cell−surface proteins on intact living cells. Aptamer recognition of extracellularly accessible targets deblocks a DNA activator, thereby activating Cas12a trans-cleavage in solution and converting localized cell−surface recognition into amplified fluorescence while maintaining a low background in the absence of targets. Using EpCAM as a model target, we engineered a split dual-aptamer architecture that enabled cooperative target recognition, efficient activator deblocking, and low-background signal amplification. The platform achieved sensitive EpCAM detection with a limit of detection of 32 fM and enabled live-cell analysis down to 2 cells/μL. It distinguished cell populations with different surface EpCAM levels and quantitatively monitored epithelial−mesenchymal transition-associated changes in cell−surface EpCAM abundance. Coordinated redesign of the target-responsive nucleic acid components extended the platform to PTK7 detection and the analysis of drug-induced cell−surface PTK7 remodeling. Coupling the system to a lateral flow readout enabled portable visual detection. This work establishes a modular and reconfigurable CRISPR-Cas12a sensing strategy for wash-free amplified quantification of cell−surface proteins on living cells, providing a convenient tool for investigating their dynamic remodeling during physiological and pathological processes and therapeutic responses, as well as for drug screening.

Analytical Chemistry
Tianjin University (CN), Nankai University (CN), Second Hospital of Tianjin Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 24%
Advanced biosensing and bioanalysis techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.